SGA

Sector Gamma AS Portfolio holdings

AUM $306M
This Quarter Return
+15.82%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$624M
AUM Growth
+$624M
Cap. Flow
-$56.5M
Cap. Flow %
-9.04%
Top 10 Hldgs %
57.01%
Holding
39
New
5
Increased
17
Reduced
15
Closed
2

Top Buys

1
MRK icon
Merck
MRK
$32.3M
2
JNJ icon
Johnson & Johnson
JNJ
$17.1M
3
BIIB icon
Biogen
BIIB
$14.8M
4
DGX icon
Quest Diagnostics
DGX
$8.22M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$6.33M

Top Sells

1
BAX icon
Baxter International
BAX
$41.3M
2
BMY icon
Bristol-Myers Squibb
BMY
$27M
3
LLY icon
Eli Lilly
LLY
$17.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
$17.8M
5
TAK icon
Takeda Pharmaceutical
TAK
$15.5M

Sector Composition

1 Healthcare 99.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$2.89B
$9.19M 1.47%
215,196
+42,218
+24% +$1.8M
DGX icon
27
Quest Diagnostics
DGX
$20.3B
$8.22M 1.32%
+76,976
New +$8.22M
THC icon
28
Tenet Healthcare
THC
$16.3B
$6.5M 1.04%
170,896
-258,781
-60% -$9.84M
BMRN icon
29
BioMarin Pharmaceuticals
BMRN
$11.2B
$6.33M 1.01%
+74,903
New +$6.33M
BLUE
30
DELISTED
bluebird bio
BLUE
$5.48M 0.88%
+62,400
New +$5.48M
PTCT icon
31
PTC Therapeutics
PTCT
$3.92B
$4.81M 0.77%
100,202
-21,200
-17% -$1.02M
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
$4.26M 0.68%
408,625
-22,800
-5% -$238K
PTLA
33
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.12M 0.5%
130,625
+4,700
+4% +$112K
AGIO icon
34
Agios Pharmaceuticals
AGIO
$2.19B
$3.05M 0.49%
63,913
-39,000
-38% -$1.86M
LLY icon
35
Eli Lilly
LLY
$657B
$2.04M 0.33%
15,524
-136,581
-90% -$17.9M
SGMO icon
36
Sangamo Therapeutics
SGMO
$157M
$1.77M 0.28%
211,698
-40,000
-16% -$335K
TAK icon
37
Takeda Pharmaceutical
TAK
$47.3B
$609K 0.1%
30,873
-785,426
-96% -$15.5M
ALNY icon
38
Alnylam Pharmaceuticals
ALNY
$58.5B
– –
-96,900
Closed -$7.79M
BAX icon
39
Baxter International
BAX
$12.7B
– –
-472,305
Closed -$41.3M
1
2